Treating or Ignoring Prostate Cancer
A new report coming out on Tuesday says a routine prostate cancer test could do more harm than good. It recommends that healthy men should not get the prostate-specific antigen, or P.S.A., exam. Some physicians argue that the test can reduce a man’s chances of dying of prostate cancer, plain and simple. But others argue that on balance, scientific studies do not support the claim that screening healthy men saves lives and in fact may cause them to have unnecessary surgery which could leave them incontinent, impotent or even death. Evaluating the risks and benefits of prostate cancer screening.
Chief of Urology at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis
acting director of the New America Foundation Health Policy Program and co-author of the New York Time Magazine article, "Can Cancer Ever Be Ignored."
University Distinguished Service Professor, The James Buchanan Brady Urological Institute, Johns Hopkins University and author of "The Patrick C. Walsh Guide to Surviving Prostate Cancer."
Associate Professor of Surgery and Chief of Urology at Howard University Hospital.